explore -WSS

explore

author：fashion 2025-09-28 02:30:26 - browse：2

Adam's take main illustration — Molly Ferguson/STAT

Roivant Sciences’ Matt Gline might be this year’s best biopharma CEO, and other thoughts about Monday’s blockbuster deal with Roche — like, why the heck did Roivant’s stock trade down?

Gline created $5 billion from $50 million — in less than one year.Regular readers know that every December, I choose a best biopharma CEO. It’s a subjective award, but deal-making acumen, management skills, and delivering shareholder value are important measuring sticks. It’s still too early to call this year’s contest, but Gline is a front-runner.

Last December, Roivant essentially acquired an experimental treatment for inflammatory bowel disease called RVT-3101 from Pfizer for $45 million and then spent another $5 million to position the drug for future Phase 3 studies. Less than a year later, Roivant flipped the drug to Roche for at least $7.1 billion.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Brain injuries and the importance of a second opinion

WSS

Life sciences investors close nearly $6 billion in new funds

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Humana sues Biden admin over Medicare Advantage audit rule

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

The (many) problems with a new study criticizing cancer screening

leisure time

explore

Wikipedia

Medical leaders decry Supreme Court decision on affirmative action

Stem cell treatment guidelines are released by FDA

Activists slam private health insurers over coverage restrictions

House transparency, PBM reform bill gains bipartisan support

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: Medeor's stem cell study, Moderna's stock dip

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In Gaza, a nonprofit 3D prints tourniquets and stethoscopes

Supreme Court strikes down use of affirmative action

NIH nominee Bertagnolli will get October confirmation hearing

entertainment

'Make People Better': The CRISPR babies story you probably don't know

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Weighted lottery helped low

The 10 drugs up first for Medicare price negotiation

All of Us, NIH's precision medicine initiative, gets a big boost

explore

Wikipedia

leisure time

hotspot